Invasive pneumococcal disease in New Zealand 1998-2005: Capsular serotypes and antimicrobial resistance

Epidemiology and Infection

Volumn 136, Issue 3, 2008, Pages 352-359

  Heffernan, Helen M ^a   Martin, D R ^a   Woodhouse, R E ^a   Morgan, J ^a   Blackmore, T K ^a,b  

^a INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

^b CAPITAL AND COAST DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFOTAXIME; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; TETRACYCLINE; VANCOMYCIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHILD; DISEASE SEVERITY; FEMALE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NEW ZEALAND; NONHUMAN; NONPARAMETRIC TEST; PATIENT REFERRAL; PENICILLIN RESISTANCE; PREVALENCE; SEROTYPE; STREPTOCOCCUS INFECTION;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEW ZEALAND; PNEUMOCOCCAL INFECTIONS; POPULATION SURVEILLANCE; PREVALENCE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 39049162778     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268807008588     Document Type: Article

References (28)

1. Green MJ, Cawley PFM. In vitro antimicrobial susceptibility of Streptococcus pneumoniae in New Zealand. New Zealand Medical Journal 1979; 90: 53-55.
2. Heffernan H. Antimicrobial susceptibility of clinically significant Streptococcus pneumoniae isolates [Letter]. New Zealand Medical Journal 1987; 100: 327.
3. Martin DR, Brett MS. Pneumococci causing invasive disease in New Zealand, 1987-94: Serogroup and serotype coverage and antibiotic resistances. New Zealand Medical Journal 1996; 109: 288-290.
4. Brett MS, Martin DR. A significant increase in antimicrobial resistance among pneumococci causing invasive disease in New Zealand. New Zealand Medical Journal 1999; 112: 113-115.
5. Immunisation Handbook 2006. Wellington: Ministry of Health, 2006.
6. Lund E, Henrichsen J. Laboratory diagnosis, serology and epidemiology of Streptococcus pneumoniae. In Bergan T, Norris R, eds. Methods in Microbiology, 12th edn. London: Academic Press, 1978, pp. 241-262.
7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement. Villanova, PA, USA: CLSI, 2006; CLSI document M100-S16.
8. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disks; approved standard - ninth edition. Villanova, PA, USA: CLSI, 2006; CLSI document M2-A9.
9. Fedson DS, Musher DM. Pneumococcal polysaccharide vaccine. In: Plotkin SA, Orenstein WA, eds. Vaccines, 4th edn. Philadelphia: Saunders, 2004, pp. 529-588.
10. Voss L, et al. Invasive pneumococcal disease in a pediatric population, Auckland, New Zealand. Pediatric Infectious Disease Journal 1994; 13: 873-878.
11. Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendation and Reports 2000; 49 (RR-9 : 1-35.
12. Drinkovic D, et al. Pneumococcal bacteraemia and opportunities for prevention. New Zealand Medical Journal 2001; 114: 326-328.
13. Institute of Environmental Science and Research. Notifiable and other diseases in New Zealand. Annual report 2005. Wellington: ESR, 2006 (http://www.surv. esr.cri.nz/surveillance/annual_surveillance.php). Accessed 21 November 2006.
14. Watson M, et al. Laboratory surveillance of invasive pneumococcal disease in Australia, 2003 - predicting the future of the universal childhood conjugate vaccine program. Communicable Disease Intelligence 2004; 28: 455-463.
15. Pedersen MK, et al. Systemic pneumococcal disease in Norway 1995-2001: Capsular serotypes and antimicrobial resistance. Epidemiology and Infection 2004; 132: 167-175.
16. Denham BC, Clarke SC. Serotype incidence and antibiotic susceptibility of Streptococcus pneumoniae causing invasive disease in Scotland. Journal of Medical Microbiology 2005; 54 327-331.
17. Reingold A, et al. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease - United States, 1998-2003. Morbidity and Mortality Weekly Report 2005; 54: 893-897.
18. Beall B, et al. Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002. Journal of Clinical Microbiology 2006; 44: 999-1017.
19. Pai R, et al. Post-vaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. Active Bacterial Core Surveillance Team. Journal of Infectious Diseases 2005; 192: 1988-1995.
20. Kyaw MH, et al. Effect of the introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. New England Journal of Medicine 2006; 354: 1455-1463.
21. European Antimicrobial Resistance Surveillance System. EARSS annual report 2004. Bilthoven: RIVM, 2005. (http://www.earss.rivm.nl). Accessed 26 June 2006.
22. Waterer GW, et al. Decreasing β-lactain resistance in pneumococci from the Memphis region. Analysis of 2,152 isolates from 1996-2001. Chest 2003; 124: 519-525.
23. Hsueh P-R. Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic use in Taiwan. Clinical Microbiology and Infection 2005; 11: 925-927.
24. Roche PW, et al. Invasive pneumococcal disease in Australia, 2004. Communicable Disease Intelligence 2006; 30: 80-92.
25. Vanderkooi OG, et al. Predicting antimicrobial resistance in invasive pneumococcal infections. Clinical Infectious Diseases 2005; 40: 1288-1297.
26. Brett MS. Emergence of a high-level cefotaxime-resistant Streptococcus pneumoniae strain in New Zealand. Journal of Medical Microbiology 2001; 50: 173-176.
27. Bean DC, Klena JD. Characterisation of major clones of antibiotic-resistant Streptococcus pneumoniae in New Zealand by multilocus sequence typing. Journal of Antimicrobial Chemotherapy 2005; 55: 375-378.
28. Stephens DS, et al. Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: Population-based assessment. Lancet 2005; 365: 855-863.